HEPATIC INSUFFICIENCY
Clinical trials for HEPATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for HEPATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested in patients with liver problems
Knowledge-focused Recruiting nowThis study looks at how the drug LY3537031 is processed by the body in people with mild, moderate, or severe liver problems compared to healthy volunteers. About 32 adults will receive a single injection under the skin. The goal is to measure drug levels in the blood and check fo…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC
-
Researchers test scoring system for rare immune disorder in ICU patients
Knowledge-focused Recruiting nowThis study looks at how well a tool called the HScore can diagnose hemophagocytic lymphohistiocytosis (HLH) in intensive care patients who also have liver failure or cirrhosis. Researchers will review medical records of 100 adults admitted to the ICU to see if the HScore accurate…
Matched conditions: HEPATIC INSUFFICIENCY
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 17, 2026 05:27 UTC
-
Liver damage drug study: no cure, just knowledge
Knowledge-focused Recruiting nowThis study looks at how the drug eloralintide is processed by the body in people with mild, moderate, or severe liver damage compared to those with healthy livers. About 36 adults will receive a single shot and stay at a clinic for 5 nights. The goal is to understand safety and d…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC